During a Senate HELP Committee hearing, RFK Jr. stated that President Trump is dedicated to bringing drug manufacturing "back ...

The pathway allows medicine developers to work with the regulators, the NHS and health technology assessment bodies.

Takeda has announced the appointment of Julie Kim as the successor to Christophe Weber, effective from June 2026.

Leveragen has announced a strategic partnership with Moonlight Bio, targeting the development of T-cell therapies for ...

Prioritising US health, Trump has already frozen the supply of HIV and malaria medication aid to endemic countries.